Field report E-55 / P6 · sheet /strategy

Corporate StrategyFiled from the territory

Applied Nutrition profit jumps 44% on GLP-1 demand

Applied Nutrition reported a 44% rise in pre-tax profit to £40.6m and 50% revenue growth to £161.6m, helped by GLP-1-linked products despite whey inflation.

Grid
E-55 / P6
Surveyed
November 16, 2026
Reading
3 min read
Correspondent
Amara Osei
Applied Nutrition profit surges as weight-loss jabs fuel demand
Fig. E-55 / P6Applied Nutrition profit surges as weight-loss jabs fuel demand — HeungSoon / pixabay

Field notes

  1. Pre-tax profit rose 44% to £40.6m in the year to end-July.
  2. Revenue increased 50% to £161.6m in the year to end-July.
  3. British weight-loss medication use rose from 3.1% in June last year to 6% in March this year.
  4. Shares gained 133% since the October 2024 IPO and 23% year to date.
  5. Thomas Ryder founded Applied Nutrition in 2014; backers include Rooney, Cowgil and Issa.

Amara Osei

Applied Nutrition increased pre-tax profit (profit before tax) by 44% to £40.6m in the year to end-July, while revenue rose 50% to £161.6m. The Merseyside-based, London-listed sports supplement maker paired that growth with demand for products designed for consumers taking GLP-1 weight-loss jabs.

Rising use of GLP-1s, the weight-loss medication category cited by Applied Nutrition, has altered both consumer demand and the economics of whey protein. The company responded with what it called the first protein-shake range specifically designed for people using those treatments.

What products target GLP-1 users?

The range includes creatine and liquid collagen pouches, plus “digest capsules” containing enzymes, probiotics and fibre. Applied Nutrition says the capsules are intended to “promote digestive comfort” and “gut health”.

British use of weight-loss medication rose from 3.1% in June last year to 6% in March this year, according to Applied Nutrition, citing Institute of Grocery Distribution research. The company therefore positioned its new range to capture demand from an expanding customer group.

Applied Nutrition told shareholders: “The global sports nutrition, health and wellness market continues to grow rapidly as consumers are becoming more health conscious.” The company added: “These shifting trends are creating opportunities across both established and emerging categories.”

The group said its GLP-1-friendly ranges helped it remain “at the forefront of the market while retaining the agility to adapt as demand changes.” It also reported stronger demand for collagen and creatine among female gym-goers, adding another source of support for its nutrition portfolio.

How has whey inflation affected margins?

Rising GLP-1 popularity partly drove soaring whey protein costs, and whey remains a crucial ingredient in Applied Nutrition’s products. Higher input prices have eaten into the company’s margins in recent months, offsetting part of the benefit from higher sales.

How is Applied Nutrition broadening its appeal?

The company has partnered with Slush Puppie, Sour Patch Kids and Swedish Fish to remain relevant among younger consumers. Those tie-ups extend its reach beyond GLP-1 users and female gym-goers into partnerships aimed at younger customers.

Thomas Ryder, a former scaffolder who founded the business in 2014, said the group enters the new financial year with “very strong momentum”. He added: “Consumer demand for health, wellness and performance nutrition continues to grow and the market is moving quickly.”

“We stay close to our customers, listen to what consumers want and move fast when we see an opportunity,” Ryder said. His operating model places rapid product adaptation close to changes in consumer demand.

Since its 2014 founding, Applied Nutrition’s rapid rise has attracted high-profile backers, including Colleen Rooney, former JD Sports boss Peter Cowgil and petrol forecourt magnate Mohsin Issa. The London listing followed more than a decade of trading for the sports supplement group.

What does the analyst say?

Milo Bussell, an analyst at stockbroker Cavendish, described the protein-shake maker as “going from strength to strength”. He called the market backdrop “highly supportive with consumers prioritising health and wellness and retailers expanding shelf space for the category”.

Bussell’s assessment identifies two supports for further category growth: consumers prioritising health and wellness, and retailers expanding shelf space. Both align with Applied Nutrition’s focus on health, performance and GLP-1-related nutrition products.

How have shares performed?

Applied Nutrition shares have gained 133% since the company’s initial public offering (IPO) in October 2024. They are up 23% in the year to date, extending the post-listing advance as revenue and profit increased.

Can growth overcome margin pressure?

The operating case rests on three demand drivers: GLP-1 medication use, female gym-goer demand for collagen and creatine, and younger consumers reached through three named partnerships. Against those opportunities, whey protein inflation has already reduced margins in recent months.

Applied Nutrition’s 50% revenue growth and 44% pre-tax profit growth show that its GLP-1 strategy has supported earnings despite the cost pressure. The strategic test is whether management can sustain rapid product adaptation while protecting margins from whey inflation.

via cityam.com (Source)

Share this article:

More from Amara Osei

Amara Osei

Show full bio

Market editor covering people, launches and day-to-day practice in corporate strategy and chief-executive leadership at CEO Frontier.

449 articles

Filed under

Adjacent sheets

« Previous articleNext article »

End of sheetE-55 / P6 · November 16, 2026